Adjusting insulin dosage for children is especially tricky due to frequent changes in body weight and insulin sensitivity as they grow. Even fast-acting insulins may not be absorbed quickly enough to get young patients to target.
A new study looks at whether the Faster-acting insulin Aspart (FIAsp), which is already approved for adults and has shown good results, is safe and effective in children.
It found that FIAsp can provide better mealtime glucose control for children, compared to current rapid-acting insulins.
Originally published at DiabetesNews.com
This article is for information only and should not be used for the diagnosis or treatment of medical conditions. Diabetes-Cure.me and the submitting author have used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. Please read our full Disclaimer.
Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for “FAIR USE” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favour of fair use. Please read our full Disclaimer.